Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Mohammad Quamruzzaman, M.D.
Internal Medicine · JAMAICA, NY · NPI 1154497865
Verified facts
What the public records show
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
Products named in Open Payments records
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1481 | 390 |
| Amlodipine Besylate | Amlodipine Besylate | 913 | 248 |
| Metformin Hcl | Metformin Hcl | 589 | 153 |
| Metoprolol Succinate | Metoprolol Succinate | 531 | 148 |
| Pantoprazole Sodium | Pantoprazole Sodium | 490 | 106 |
| Gabapentin | Gabapentin | 444 | 108 |
| Losartan Potassium | Losartan Potassium | 444 | 129 |
| Tamsulosin Hcl | Tamsulosin Hcl | 438 | 117 |
| Levothyroxine Sodium | Levothyroxine Sodium | 431 | 105 |
| Alendronate Sodium | Alendronate Sodium | 418 | 101 |
| Lisinopril | Lisinopril | 412 | 116 |
| Famotidine | Famotidine | 356 | 92 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 345 | 98 |
| Omeprazole | Omeprazole | 338 | 86 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 296 | 69 |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 282 | 97 |
| Janumet | Sitagliptin Phos/Metformin Hcl | 276 | 50 |
| Farxiga | Dapagliflozin Propanediol | 271 | 69 |
| Simvastatin | Simvastatin | 265 | 69 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 263 | 61 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 238 | 62 |
| Jardiance | Empagliflozin | 236 | 65 |
| Furosemide | Furosemide | 227 | 77 |
| Metoprolol Tartrate | Metoprolol Tartrate | 220 | 53 |
| Finasteride | Finasteride | 218 | 55 |
| Hydrochlorothiazide | Hydrochlorothiazide | 206 | 60 |
| Eliquis | Apixaban | 196 | 44 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 187 | 52 |
| Hydralazine Hcl | Hydralazine Hcl | 187 | 53 |
| Meclizine Hcl | Meclizine Hcl | 181 | 46 |
| Montelukast Sodium | Montelukast Sodium | 175 | 48 |
| Januvia | Sitagliptin Phosphate | 172 | 36 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 167 | 34 |
| Ozempic | Semaglutide | 162 | 35 |
| Nifedipine Er | Nifedipine | 156 | 44 |
| Trulicity | Dulaglutide | 154 | 30 |
| Ezetimibe | Ezetimibe | 143 | 44 |
| Easy Touch Alcohol Prep Pads | Alcohol Antiseptic Pads | 139 | 49 |
| Carvedilol | Carvedilol | 123 | 35 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 122 | 34 |
| Pioglitazone Hcl | Pioglitazone Hcl | 118 | 29 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 115 | 26 |
| Single Use Swab | Alcohol Antiseptic Pads | 111 | 37 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 106 | 39 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 98 | 48 |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 96 | 23 |
| Spironolactone | Spironolactone | 93 | 24 |
| Novolog Flexpen | Insulin Aspart | 91 | 26 |
| Glipizide | Glipizide | 89 | 21 |
| Donepezil Hcl | Donepezil Hcl | 88 | 30 |
| Enalapril Maleate | Enalapril Maleate | 83 | 16 |
| Levemir Flexpen | Insulin Detemir | 83 | 27 |
| Mirtazapine | Mirtazapine | 80 | 17 |
| Meloxicam | Meloxicam | 78 | 28 |
| Ramipril | Ramipril | 78 | 21 |
| Clopidogrel | Clopidogrel Bisulfate | 77 | 23 |
| Acarbose | Acarbose | 76 | 16 |
| Entresto | Sacubitril/Valsartan | 76 | 20 |
| Labetalol Hcl | Labetalol Hcl | 74 | 26 |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 74 | 22 |
| Atenolol | Atenolol | 72 | 17 |
| Metformin Hcl Er | Metformin Hcl | 71 | 16 |
| Valsartan | Valsartan | 71 | 17 |
| Baclofen | Baclofen | 67 | 15 |
| Allopurinol | Allopurinol | 66 | 16 |
| Chlorthalidone | Chlorthalidone | 66 | 18 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 66 | 15 |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 66 | 15 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 63 | 16 |
| Levetiracetam | Levetiracetam | 62 | 13 |
| Alcohol Pads | Alcohol Antiseptic Pads | 61 | 30 |
| Glipizide Er | Glipizide | 60 | 15 |
| Diclofenac Sodium | Diclofenac Sodium | 58 | 26 |
| Tradjenta | Linagliptin | 58 | 12 |
| Memantine Hcl | Memantine Hcl | 57 | 15 |
| Pravastatin Sodium | Pravastatin Sodium | 49 | 14 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 45 | 17 |
| Glimepiride | Glimepiride | 44 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 41 | 17 |
| Fluticasone Propionate | Fluticasone Propionate | 40 | 16 |
| Pentoxifylline | Pentoxifylline | 40 | suppressed |
| Pro Comfort Alcohol Pads | Alcohol Antiseptic Pads | 40 | 13 |
| Xarelto | Rivaroxaban | 40 | suppressed |
| Alcohol Swabs | Alcohol Antiseptic Pads | 39 | 15 |
| Folic Acid | Folic Acid | 37 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 35 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 34 | suppressed |
| Sertraline Hcl | Sertraline Hcl | 34 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 31 | 12 |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 31 | 13 |
| Comfort Ez Pen Needle | Pen Needle, Diabetic | 30 | 11 |
| Ventolin Hfa | Albuterol Sulfate | 30 | suppressed |
| Ketoconazole | Ketoconazole | 29 | 11 |
| Novolog Mix 70-30 Flexpen | Insulin Aspart Prot/Insuln Asp | 29 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 29 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 29 | 16 |
| True Comfort Pro Alcohol Pads | Alcohol Antiseptic Pads | 27 | 12 |
| True Comfort Safety Pen Needle | Pen Needle, Diabetic, Safety | 27 | 11 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 26 | suppressed |
| Comfort Ez Pro Safety Pen Ndl | Pen Needle, Diabetic, Safety | 26 | suppressed |
| Lovastatin | Lovastatin | 26 | suppressed |
| Repaglinide | Repaglinide | 26 | suppressed |
| Trazodone Hcl | Trazodone Hcl | 25 | suppressed |
| Potassium Chloride | Potassium Chloride | 24 | 12 |
| Ultra-Fine Micro Pen Needle | Pen Needle, Diabetic | 24 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 24 | suppressed |
| Calcitriol | Calcitriol | 23 | suppressed |
| Cilostazol | Cilostazol | 23 | suppressed |
| Methimazole | Methimazole | 23 | suppressed |
| Vascepa | Icosapent Ethyl | 23 | suppressed |
| Azithromycin | Azithromycin | 22 | 21 |
| Fenofibrate | Fenofibrate | 22 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 21 | suppressed |
| Lokelma | Sodium Zirconium Cyclosilicate | 21 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 21 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 20 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 20 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 20 | suppressed |
| Fosinopril Sodium | Fosinopril Sodium | 18 | suppressed |
| Alcohol Swab | Alcohol Antiseptic Pads | 17 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 17 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 17 | suppressed |
| Ranolazine Er | Ranolazine | 17 | suppressed |
| Unifine Safecontrol Pen Needle | Pen Needle,dual Safety,diabetc | 17 | suppressed |
| Clotrimazole | Clotrimazole | 16 | suppressed |
| Colchicine | Colchicine | 16 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 15 | suppressed |
| Primidone | Primidone | 15 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 14 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 14 | suppressed |
| Nateglinide | Nateglinide | 14 | suppressed |
| Gemfibrozil | Gemfibrozil | 13 | suppressed |
| Jentadueto | Linagliptin/Metformin Hcl | 13 | suppressed |
| Novolog Mix 70-30 | Insulin Aspart Prot/Insuln Asp | 13 | suppressed |
| Cartia Xt | Diltiazem Hcl | 12 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 12 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 12 | suppressed |
| Dulera | Mometasone/Formoterol | 12 | suppressed |
| Prednisone | Prednisone | 12 | suppressed |
| Creon | Lipase/Protease/Amylase | 11 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 11 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 11 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 11 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error